Biosimilar Uptake Surges After Order Set Change at Academic Infusion Center

By Gina ShawSwitching the default product in electronic order sets from originator biologics to preferred formulary biosimilars dramatically increased biosimilar utilization for commonly prescribed oncology infusion agents, according to a presentation from researchers at the University of Arkansas for Medical Sciences (UAMS) at HOPA 2026, in New Orleans (poster CR08).figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure im